1. Multiple Sclerosis & Neurorepair Research Unit, Biogen, Cambridge, United States
2. Department of Pharmacology & Experimental Therapeutics, Boston University School of Medicine, Boston, United States
3. Emerging Neurosciences Research Unit, Biogen, Cambridge, United States
4. Chemical Biology and Proteomics, Cambridge, United States
5. Multiple Sclerosis Development Unit, Biogen, Cambridge, United States
6. Center for Genomic Medicine, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, United States
7. Third Rock Ventures, Boston, United States